|
Supplier News Breaks Archives Start-up ShelfX has launched a wireless checkout and inventory management system for retailers that it said enables customers to shop without cashiers. Mylan Inc. is launching morphine sulfate extended-release tablets, an opioid analgesic for the treatment of moderate to severe pain. Canada's National Advisory Committee on Immunization (NACI) has designated FluMist, AstraZeneca's nasal spray flu vaccine, as the preferred flu vaccination for children ages 2 to 17 without chronic health conditions. Abbott has introduced Glucerna Hunger Smart nutrition shakes and nutrition bars for people with diabetes. Help Remedies, a maker of "minimalist" over-the-counter medicines, is hitting the shelves at Walgreens. Teva Pharmaceutical Industries Ltd. and Dr. Reddy’s Laboratories (NYSE: RDY) announced the commercial launch of olanzapine tablets, an antipsychotic medication. As of next year, Kao Brands Co. will go under a new company name: Kao USA Inc. Sanofi has appointed David Meeker as chief executive officer of its biotechnology subsidiary Genzyme Corp.
|